Bone Morphogenic Proteins: Applications in Spinal Surgery


The prospect of predictable and reliable oseteogenesis without the need for secondary bone grafting to treat a wide spectrum of spinal disorders is tremendously appealing. Recombinant human bone morphogenic proteins (rhBMP) have been the subject of extensive basic science, animal, and clinical research as a potential therapeutic modality to promote bony fusion. Animal studies and prospective, randomized clinical trials have demonstrated the efficacy of rhBMPs as an adjunct or substitute to autogenous bone graft in the specific treatment of certain spinal conditions. The future role of rhBMPs in spinal surgery applications remains to be determined and will be dependent upon future investigations evaluating 1) the efficacy in a variety of spinal conditions and environments, 2) the optimal dose and delivery system, 3) the long-term safety profile (immunogenicity, antibody formation), and 4) the cost effectiveness of these therapeutic growth factors.

This is a preview of subscription content, log in to check access.


  1. 1.

    JC Steinmann HN Herkowitz (1992) ArticleTitlePseudarthrosis of the spine Clin Orthop Relat Res 284 80–90 Occurrence Handle1395317

    PubMed  Google Scholar 

  2. 2.

    CJ Damien JR Parsons (1991) ArticleTitleBone graft and bone graft substitutes: a review of current technology and applications J Appl Biomater 2 IssueID3 187–208 Occurrence Handle10.1002/jab.770020307 Occurrence Handle10149083

    Article  PubMed  Google Scholar 

  3. 3.

    BN Summers SM Eisenstein (1989) ArticleTitleDonor site pain from the ilium. A complication of lumbar spine fusion J Bone Joint Surg Br 71 IssueID4 677–680 Occurrence Handle2768321

    PubMed  Google Scholar 

  4. 4.

    EM Younger MW Chapman (1989) ArticleTitleMorbidity at bone graft donor sites J Orthop Trauma 3 IssueID3 192–195 Occurrence Handle2809818

    PubMed  Google Scholar 

  5. 5.

    SS Jorgenson (1994) ArticleTitleA prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients Spine 19 IssueID8 2048–2053 Occurrence Handle7825044

    PubMed  Google Scholar 

  6. 6.

    PJ Nugent EG Dawson (1993) ArticleTitleIntertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graft Clin Orthop Relat Res 287 107–111 Occurrence Handle8448926

    PubMed  Google Scholar 

  7. 7.

    TS Lindholm P Ragni TC Lindholm (1988) ArticleTitleResponse of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits Clin Orthop Relat Res 230 296–302 Occurrence Handle3284680

    PubMed  Google Scholar 

  8. 8.

    J Oikarinen (1982) ArticleTitleExperimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbits Clin Orthop Relat Res 162 210–218 Occurrence Handle7039912

    PubMed  Google Scholar 

  9. 9.

    CG Finkemeier (2002) ArticleTitleBone-grafting and bone-graft substitutes J Bone Joint Surg Am 84-A IssueID3 454–464 Occurrence Handle11886919

    PubMed  Google Scholar 

  10. 10.

    MR Urist (1965) ArticleTitleBone: formation by autoinduction Science 150 IssueID698 893–899 Occurrence Handle5319761

    PubMed  Google Scholar 

  11. 11.

    TK Sampath et al. (1990) ArticleTitleBovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily J Biol Chem 265 IssueID22 13198–13205

    Google Scholar 

  12. 12.

    TK Sampath AH Reddi (1981) ArticleTitleDissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation Proc Natl Acad Sci U S A 78 IssueID12 7599–7603

    Google Scholar 

  13. 13.

    Boden SD (1999) Bioactive factors for bone tissue engineering. Clin Orthop Relat Res (367 Suppl):S84–S94

  14. 14.

    FP Luyten et al. (1989) ArticleTitlePurification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation J Biol Chem 264 IssueID23 13377–13380

    Google Scholar 

  15. 15.

    E Ozkaynak et al. (1990) ArticleTitleOP-1 cDNA encodes an osteogenic protein in the TGF-beta family EMBO J 9 IssueID7 2085–2093 Occurrence Handle2357959

    PubMed  Google Scholar 

  16. 16.

    T Katagiri et al. (1990) ArticleTitleThe non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2 Biochem Biophys Res Commun 172 IssueID1 295–299 Occurrence Handle10.1016/S0006-291X(05)80208-6 Occurrence Handle1699539

    Article  PubMed  Google Scholar 

  17. 17.

    Y Takuwa et al. (1991) ArticleTitleBone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells MC3T3-E1 Biochem Biophys Res Commun 174 IssueID1 96–101 Occurrence Handle10.1016/0006-291X(91)90490-X Occurrence Handle1989624

    Article  PubMed  Google Scholar 

  18. 18.

    LC Yeh et al. (1998) ArticleTitleOsteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms J Cell Physiol 175 IssueID1 78–88 Occurrence Handle10.1002/(SICI)1097-4652(199804)175:1<78::AID-JCP9>3.0.CO;2-9 Occurrence Handle9491783

    Article  PubMed  Google Scholar 

  19. 19.

    LC Yeh JC Lee (1999) ArticleTitleOsteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells Mol Cell Endocrinol 153 IssueID1–2 113–124 Occurrence Handle10.1016/S0303-7207(99)00076-3 Occurrence Handle10459859

    Article  PubMed  Google Scholar 

  20. 20.

    LC Yeh R Unda JC Lee (2000) ArticleTitleOsteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts J Cell Physiol 185 IssueID1 87–97 Occurrence Handle10.1002/1097-4652(200010)185:1<87::AID-JCP8>3.0.CO;2-8 Occurrence Handle10942522

    Article  PubMed  Google Scholar 

  21. 21.

    Food and Drug Administration (2002) Document P000058-InFUSE Bone Graft/LT-CAGE lumbar tapered fusion device.

  22. 22.

    Sandhu H, Kabo JM, Turner AS (1996) rhBMP-2 augmentation of titanium fusion cages for experimental anterior lumbar fusion. Presented at the Annual Meeting of the North American Spine Society

  23. 23.

    HS Sandhu et al. (2002) ArticleTitleHistologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion Spine 27 IssueID6 567–575 Occurrence Handle10.1097/00007632-200203150-00003 Occurrence Handle11884903

    Article  PubMed  Google Scholar 

  24. 24.

    Zdeblick TA, Heim SE, Kleeman TJ (2001) Laparoscopic approach with tapered metal cages: rhBMP-2 vs. autograft. Presented at the Annual Meeting of the North American Spine Society, 31 Oct–3 Nov, Seattle, WA

  25. 25.

    SD Boden et al. (1998) ArticleTitleLaparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage J Spinal Disord 11 IssueID2 95–101 Occurrence Handle9588464

    PubMed  Google Scholar 

  26. 26.

    BP Hecht et al. (1999) ArticleTitleThe use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model Spine 24 IssueID7 629–636 Occurrence Handle10.1097/00007632-199904010-00004 Occurrence Handle10209790

    Article  PubMed  Google Scholar 

  27. 27.

    HS Sandhu et al. (1995) ArticleTitleEvaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model Spine 20 IssueID24 2669–2682 Occurrence Handle8747245

    PubMed  Google Scholar 

  28. 28.

    HS Sandhu et al. (1996) ArticleTitleEffective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion Spine 21 IssueID18 2115–2122 Occurrence Handle10.1097/00007632-199609150-00012 Occurrence Handle8893436

    Article  PubMed  Google Scholar 

  29. 29.

    HS Sandhu et al. (1997) ArticleTitleExperimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements Spine 22 IssueID11 1171–1180 Occurrence Handle10.1097/00007632-199706010-00001 Occurrence Handle9201852

    Article  PubMed  Google Scholar 

  30. 30.

    JS Fischgrund et al. (1997) ArticleTitleAugmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model J Spinal Disord 10 IssueID6 467–472

    Google Scholar 

  31. 31.

    JH Schimandle SD Boden WC Hutton (1995) ArticleTitleExperimental spinal fusion with recombinant human bone morphogenetic protein-2 Spine 20 IssueID12 1326–1337 Occurrence Handle7676329

    PubMed  Google Scholar 

  32. 32.

    GJ Martin SuffixJr et al. (1999) ArticleTitlePosterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety J Spinal Disord 12 IssueID3 179–186 Occurrence Handle10382769

    PubMed  Google Scholar 

  33. 33.

    SD Boden et al. (1999) ArticleTitlePosterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate Spine 24 IssueID12 1179–1185 Occurrence Handle10.1097/00007632-199906150-00002 Occurrence Handle10382242

    Article  PubMed  Google Scholar 

  34. 34.

    DY Suh et al. (2002) ArticleTitleDelivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate Spine 27 IssueID4 353–360 Occurrence Handle10.1097/00007632-200202150-00006 Occurrence Handle11840099

    Article  PubMed  Google Scholar 

  35. 35.

    Suh DY, Boden SD, Ugbo JL (2002) Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons, Dallas, TX, 13–17 Feb 2002

  36. 36.

    Minamide A et al (2001) Use of rhBMP-2 supplemented with allograft bone chips in posterolateral fusions in nonhuman primates. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001

  37. 37.

    GJ Martin SuffixJr SD Boden L Titus (1999) ArticleTitleRecombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion Spine 24 IssueID21 2188–2193 Occurrence Handle10.1097/00007632-199911010-00003 Occurrence Handle10562982

    Article  PubMed  Google Scholar 

  38. 38.

    SD Boden et al. (2000) ArticleTitleThe use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report Spine 25 IssueID3 376–381 Occurrence Handle10.1097/00007632-200002010-00020 Occurrence Handle10703113

    Article  PubMed  Google Scholar 

  39. 39.

    Gornet MF, Burkus K, Dickman CA (2001) rhBMP-2 with tapered cages: a prospective, randomized lumbar fusion study. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001

  40. 40.

    JK Burkus et al. (2002) ArticleTitleAnterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages J Spinal Disord Tech 15 IssueID5 337–349 Occurrence Handle12394656

    PubMed  Google Scholar 

  41. 41.

    JK Burkus et al. (2002) ArticleTitleClinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2 Spine 27 IssueID21 2396–2408 Occurrence Handle10.1097/00007632-200211010-00015 Occurrence Handle12438990

    Article  PubMed  Google Scholar 

  42. 42.

    SD Boden et al. (2002) ArticleTitleUse of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 IssueID23 2662–2673 Occurrence Handle10.1097/00007632-200212010-00005 Occurrence Handle12461392

    Article  PubMed  Google Scholar 

  43. 43.

    Luque E (2002) Latest clinical results using demineralized bone materials and rhBMP-2: The Mexican experience. Presented at Total Spine: Advanced Concepts and Constructs, Cancun, Mexico

  44. 44.

    Food and Drug Administration (2001) Document H010002, OP-1 Implant.

  45. 45.

    Food and Drug Administration (2004) Document H020008, OP-1 Putty.

  46. 46.

    SD Cook et al. (1994) ArticleTitleIn vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions Spine 19 IssueID15 1655–1663 Occurrence Handle7973957

    PubMed  Google Scholar 

  47. 47.

    JN Grauer et al. (2001) ArticleTitle2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion Spine 26 IssueID2 127–133 Occurrence Handle10.1097/00007632-200101150-00004 Occurrence Handle11154530

    Article  PubMed  Google Scholar 

  48. 48.

    BW Cunningham et al. (2002) ArticleTitleOsseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction Spine J 2 IssueID1 11–24 Occurrence Handle10.1016/S1529-9430(01)00170-X Occurrence Handle14588284

    Article  PubMed  Google Scholar 

  49. 49.

    MN Magin G Delling (2001) ArticleTitleImproved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep Spine 26 IssueID5 469–478 Occurrence Handle10.1097/00007632-200103010-00009 Occurrence Handle11242373

    Article  PubMed  Google Scholar 

  50. 50.

    BW Cunningham et al. (1999) ArticleTitleOsteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device Spine 24 IssueID6 509–518 Occurrence Handle10.1097/00007632-199903150-00002 Occurrence Handle10101812

    Article  PubMed  Google Scholar 

  51. 51.

    Chirossel JP, Gay E, Boutrand JP, et al (2000) Stryker spine PEEK and titanium cages: interbody fusion with OP-1 (BMP-7) vs. autograft in a sheep model. Presented at the EuroSpine meeting, Antwerp, Belgium

  52. 52.

    TC Patel et al. (2001) ArticleTitleOsteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion Spine 26 IssueID15 1656–1661 Occurrence Handle10.1097/00007632-200108010-00004 Occurrence Handle11474350

    Article  PubMed  Google Scholar 

  53. 53.

    Speck G (2000) Posterolateral fusion using OP-1: a model using degenerative spondylolisthesis. Presented at the Australian Spine Meeting, Adelaide, Australia

  54. 54.

    Patel TC, Vaccaro AR, Truumees E et al (2001) A safety and efficacy study of OP-1 (rhBMP-7) as an adjunct to posterolateral lumbar fusion. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA, 31 Oct–3 Nov 2001

  55. 55.

    Vaccaro AR et al (2005) A 2-Year follow-up pilot study evaluating the safety and efficacy of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (in press)

  56. 56.

    AR Vaccaro et al. (2004) ArticleTitleA pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis Spine 29 IssueID17 1885–1892 Occurrence Handle10.1097/01.brs.0000137062.79201.98 Occurrence Handle15534410

    Article  PubMed  Google Scholar 

  57. 57.

    AR Vaccaro et al. (2003) ArticleTitleA pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions Eur Spine J 12 IssueID5 495–500 Occurrence Handle10.1007/s00586-003-0561-8 Occurrence Handle12908103

    Article  PubMed  Google Scholar 

  58. 58.

    Sandhu HS, Kanim LE, Dawson ED (1997) The safety and efficacy of purified native human bone morphogenic protein for spinal fusion. A ten-Year follow-up study. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons, San Francisco, CA, 13–17 Feb 1997

  59. 59.

    P Roux ParticleLe et al. (1999) ArticleTitleOP-1 enhances dendritic growth from cerebral cortical neurons in vitro Exp Neurol 160 IssueID1 151–163 Occurrence Handle10.1006/exnr.1999.7194 Occurrence Handle10630200

    Article  PubMed  Google Scholar 

  60. 60.

    MN Helder et al. (1995) ArticleTitleExpression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development J Histochem Cytochem 43 IssueID10 1035–1044 Occurrence Handle7560881

    PubMed  Google Scholar 

  61. 61.

    M Solursh et al. (1996) ArticleTitleOsteogenic protein-1 is required for mammalian eye development Biochem Biophys Res Commun 218 IssueID2 438–443 Occurrence Handle10.1006/bbrc.1996.0078 Occurrence Handle8561774

    Article  PubMed  Google Scholar 

  62. 62.

    E Ozkaynak et al. (1997) ArticleTitleOsteogenic protein-1 mRNA in the uterine endometrium Biochem Biophys Res Commun 234 IssueID1 242–246 Occurrence Handle10.1006/bbrc.1997.6624 Occurrence Handle9168996

    Article  PubMed  Google Scholar 

  63. 63.

    DW Polly SuffixJr et al. (2003) ArticleTitleA cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion Orthopedics 26 IssueID10 1027–1037 Occurrence Handle14577525

    PubMed  Google Scholar 

  64. 64.

    S Tim Yoon et al. (2003) ArticleTitleThe effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro Spine 28 IssueID16 1773–1780 Occurrence Handle10.1097/01.BRS.0000083204.44190.34 Occurrence Handle12923462

    Article  PubMed  Google Scholar 

  65. 65.

    J Li ST Yoon WC Hutton (2004) ArticleTitleEffect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells J Spinal Disord Tech 17 IssueID5 423–428 Occurrence Handle10.1097/01.bsd.0000112084.85112.5d Occurrence Handle15385883

    Article  PubMed  Google Scholar 

  66. 66.

    S Sobajima et al. (2005) ArticleTitleQuantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction Spine J 5 IssueID1 14–23 Occurrence Handle10.1016/j.spinee.2004.05.251 Occurrence Handle15653081

    Article  PubMed  Google Scholar 

  67. 67.

    R Takae et al. (1999) ArticleTitleImmunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral disc Spine 24 IssueID14 1397–1401 Occurrence Handle10.1097/00007632-199907150-00002 Occurrence Handle10423782

    Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to James Farmer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jeong, G.K., Sandhu, H.S. & Farmer, J. Bone Morphogenic Proteins: Applications in Spinal Surgery. HSS Jrnl 1, 110–117 (2005).

Download citation

Key words

  • bone morphogenic protein
  • arthrodesis
  • spinal fusion
  • growth factor
  • osteogenic protein-1
  • recombinant human bone morphogenic protein-2